Gunderson Dettmer has advised Kleiner Perkins. Kleiner Perkins has announced the formation of two new investment funds totaling $3.5 billion, comprising KP22, a $1 billion venture...
Kleiner Perkins Launches $3.5 Billion in New Venture and Growth Funds
SignalFire’s $1 Billion Funding Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented SignalFire in the transaction. SignalFire, a leading venture capital firm known for its data-driven investment approach, announced the...
DCVC Bio’s $400 Million Closing of DCVC Bio III
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented DCVC Bio in the transaction. DCVC Bio announced the formation of its $400 million fund, DCVC Bio III....
Kleiner Perkins’ $2 Billion Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Kleiner Perkins in the deal. Kleiner Perkins Caufield & Byers (KPCB) announced its twenty first venture fund, KP21,...
Ironspring Ventures’ $100 Million Formation of Fund II
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Ironspring Ventures in the deal. Ironspring Ventures announced the formation of Ironspring Fund II, a $100 million fund....
Matter Venture Partners’ $300 Million Inaugural Fund
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Matter Venture Partners in the transaction. Matter Venture Partners announced the formation of its $300 million inaugural fund....
Ballistic Ventures’ Closing of Fund II at $360 Million
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Ballistic Ventures in the deal. Ballistic Ventures announced it closed its $360 million second fund formation. The company...
ABS Capital’s Closing of First Continuation Fund
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ABS Capital in the deal. ABS Capital announced the closing of its first continuation fund, a GP-led secondary transaction...
Westlake Village BioPartners’ $450 Million Fund Formation
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Westlake Village BioPartners in the fund formation. Westlake Village BioPartners announced the formation of its $450 million new fund. The...
Correlation Ventures’ $130 Million Fund Formation
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Correlation Ventures in the deal. Correlation Ventures announced the close of Correlation III, a $130M US venture capital fund. Correlation...
Cowboy Ventures’ Closing of Cowboy Fund IV and Mustang Fund
Gunderson Dettmer represented Cowboy Ventures on the deal. Cowboy Ventures announced the closing of two new funds, Cowboy Ventures Fund IV and Cowboy Mustang Fund I, its...
Conviction Partners’ $101 Million Debut Fund
Gunderson Dettmer represented Conviction Partners on the deal. Conviction Partners announced its debut fund. The fund will invest in early stage AI companies. The Gunderson Dettmer team...